Methods of treating an injury to, or disorder of, the eye involving photoreceptor proliferation by administering VEGF2 antibodies

作者: Viktor Roschke , Steven M. Ruben , Ralph Alderson , Craig A. Rosen , Robert Melder

DOI:

关键词:

摘要: The present invention is directed to VEGF-2 polynucleotides and polypeptides methods of using such polypeptides. In particular, provided are treating retinal disorders with

参考文章(145)
Lena Claesson-Welsh, Katri Pajusola, Kari Alitalo, Olga Aprelikova, Herbert Weich, Giuliana Pelicci, Signalling properties of FLT4, a proteolytically processed receptor tyrosine kinase related to two VEGF receptors. Oncogene. ,vol. 9, pp. 3545- 3555 ,(1994)
Alitalo K, Maglione D, Aprelikova O, Viglietto G, Chou Jy, Ferraro Mg, Lei Kj, Del Vecchio S, Guerriero, Persico Mg, Two alternative mRNAs coding for the angiogenic factor, placenta growth factor (PlGF), are transcribed from a single gene of chromosome 14. Oncogene. ,vol. 8, pp. 925- 931 ,(1993)
Gail M. Seigel, The golden age of retinal cell culture. Molecular Vision. ,vol. 5, pp. 4- ,(1999)
Liang Cao, Jing-Shan Hu, Craig A. Rosen, Antibodies to human vascular endothelial growth factor 2 ,(2001)
Paul S. Meissner, Mark D. Adams, Rebecca A. Fuldner, Transforming growth factor αH1 ,(1994)
Mark A. Rampy, Reiner L. Gentz, Roxanne Duan, Steven M. Ruben, Donna Mendrick, Timothy A. Coleman, Paul A. Moore, Pablo Jimenez, Jian Ni, Jun Zhang, KERATINOCYTE GROWTH FACTOR-2 (KGF-2 OR FIBROBLAST GROWTH FACTOR-12, FGF-12) Mutants ,(1997)